key: cord-0821644-nxj2lpy9
authors: Razmienė, Beatričė; Řezníčková, Eva; Dambrauskienė, Vaida; Ostruszka, Radek; Kubala, Martin; Žukauskaitė, Asta; Kryštof, Vladimír; Šačkus, Algirdas; Arbačiauskienė, Eglė
title: Synthesis and Antiproliferative Activity of 2,4,6,7-Tetrasubstituted-2H-pyrazolo[4,3-c]pyridines
date: 2021-11-08
journal: Molecules
DOI: 10.3390/molecules26216747
sha: ae12d07d63f9ed0b8e40711f9518db57842f26f1
doc_id: 821644
cord_uid: nxj2lpy9

A library of 2,4,6,7-tetrasubstituted-2H-pyrazolo[4,3-c]pyridines was prepared from easily accessible 1-phenyl-3-(2-phenylethynyl)-1H-pyrazole-4-carbaldehyde via an iodine-mediated electrophilic cyclization of intermediate 4-(azidomethyl)-1-phenyl-3-(phenylethynyl)-1H-pyrazoles to 7-iodo-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridines followed by Suzuki cross-couplings with various boronic acids and alkylation reactions. The compounds were evaluated for their antiproliferative activity against K562, MV4-11, and MCF-7 cancer cell lines. The most potent compounds displayed low micromolar GI(50) values. 4-(2,6-Diphenyl-2H-pyrazolo[4,3-c]pyridin-7-yl)phenol proved to be the most active, induced poly(ADP-ribose) polymerase 1 (PARP-1) cleavage, activated the initiator enzyme of apoptotic cascade caspase 9, induced a fragmentation of microtubule-associated protein 1-light chain 3 (LC3), and reduced the expression levels of proliferating cell nuclear antigen (PCNA). The obtained results suggest a complex action of 4-(2,6-diphenyl-2H-pyrazolo[4,3-c]pyridin-7-yl)phenol that combines antiproliferative effects with the induction of cell death. Moreover, investigations of the fluorescence properties of the final compounds revealed 7-(4-methoxyphenyl)-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridine as the most potent pH indicator that enables both fluorescence intensity-based and ratiometric pH sensing.

Despite being rarely found in nature, presumably due to the difficulty of forming N-N bonds in living organisms, naturally occurring pyrazoles are prominent in laboratories due to their vast variety of biological activities [1] . In current medicinal chemistry, the incorporation of a pyrazole nucleus is a common practice to develop new drug-like molecules with anti-cancer, anti-diabetic, anti-viral, anti-inflammatory, anti-bacterial, anti-fungal, antineurodegenerative, anti-tubercular, anthelmintic, antimalarial, and photosensitizing properties [2] [3] [4] [5] [6] [7] [8] [9] [10] , among others, thus giving rise to a great number of approved therapeutics [11] . Besides numerous biological activities, pyrazoles have also been documented to possess dyeing and fluorescence properties [12] [13] [14] [15] [16] , and some of them can be used as colorimetric or fluorescent probes for sensing small molecules, ions, or pH [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] , which may have applications in in vivo imaging [29] [30] [31] . Pyrazolopyridines are among the most studied condensed pyrazole systems in organic and pharmaceutical chemistry ( Figure 1 ). For instance, 6-(3,5-dimethoxyphenyl)-3-(4-fluorophenyl)-1H-pyrazolo [3,4-b] pyridine (APcK110) is an extensively researched Kit kinase inhibitor [32] [33] [34] . More recently, various 1H-pyrazolo [3,4b] pyridine derivatives were reported as potent ALK-L1196M [35] and CDK8 inhibitors [36] , PPARα agonists [37] , and antimicrobial, anti-quorum-sensing, and anticancer agents [38] , while 3-amino-1H-pyrazolo [3,4-b] pyridine core was identified as a novel scaffold for MELK kinase inhibitors [39] . 2-{[2-(1H-Pyrazolo [3,4-c] pyridin-3-yl)-6-(trifluoromethyl)pyrimidin-4-yl]amino}ethanol is a bacterial DNA ligase inhibitor [40] , several compounds bearing 1H-pyrazolo [4,3-b] pyridin-3-amine scaffold act as positive allosteric modulators of the metabotropic glutamate receptor 4 (mGlu 4 ) [41, 42] , 3-phenylpyrazolo [3,4-c] pyridines were reported to possess antiproliferative activity [43] , and 1-(4-methoxybenzyl)-7-(4methylpiperazin-1-yl)-N-[4-(4-methylpiperazin-1-yl)phenyl]-3-phenyl-1H-pyrazolo [3,4c] pyridin-5-amine was suggested as potential angiogenesis inhibitor [44] . Among biologically active pyrazolo [4,3-c] pyridines, 3-amino-2-phenyl-2H-pyrazolo [4,3-c] pyridine-4,6diol has shown inhibitory activity against p90 ribosomal S6 kinases 2 (RSK2) [45] , while 3-aminopyrazolopyridinone derivatives were demonstrated to exhibit moderate inhibitory potency against CK1d, p38a, and aurora A kinases [46] . In a continuation of our work devoted to the preparation and study of the properties of various condensed and aryl coupled pyrazole derivatives [47] [48] [49] [50] [51] [52] [53] [54] [55] , we recently reported a structure-activity relationship study on 2,4,6-trisubstituted-2H-pyrazolo [4,3-c] pyridines, several of which displayed good anticancer activity in vitro through arresting cell cycle in mitosis and the induction of apoptosis [54] . Inspired by these results, in the current work, we prepared a library of 2,4,6,7-tetrasubstituted-2H-pyrazolo [4,3-c] pyridines and examined the influence of an additional substituent at the 7-position on the biological and optical properties of the compounds.

1-Phenyl-3-(2-phenylethynyl)-1H-pyrazole-4-carbaldehyde 2, which served as a starting material in this study, was prepared via a multi-step synthetic route from 1-phenyl-1H-pyrazol-3-ol 1 in accordance with a previously published procedure [56] (Scheme S1, Supplementary File). Then, primary alcohol 3 was obtained via the reduction of an alde-hyde group [57] (Scheme 1). Sodium borohydride was chosen as a reducing agent, and the reaction was carried out in methanol at 0 • C under an argon atmosphere. The reaction mixture was protonated with an aqueous ammonium chloride solution to create primary alcohol 3 from the intermediate complex. For the synthesis of secondary alcohols 4-7, carbaldehyde 2 was dissolved in THF and reacted with an appropriate alkyl or arylmagnesium halogenide at room temperature by adopting a previously reported procedure [58] . The reaction was carried out under an argon atmosphere with a dry solvent due to the sensitivity of Grignard reagents to air and moisture [59] . Although it is known that this kind of secondary alcohol might be unstable [51] , all of them were successfully purified by column chromatography, and their structures were determined with spectroscopic data. Scheme 1. Synthesis of 4-substituted 7-iodo-2,6-diphenyl-2H-pyrazolo [4,3-c] pyridines (13) (14) (15) (16) (17) . Rea-117 gents and conditions: i: in accordance to ref. [56] ; ii: NaBH4 and MeOH at 0 °C for 30 min (for 3); 118 MeMgBr, EtMgBr, iPrMgCl, or PhMgBr and THF (abs.) at rt for 10 min (for 4, 5, 6 and 7); iii: TMSN3, 119 BF3•Et2O, and DCM at rt for 30 min; iv: K3PO4 (for 13 and 17) or NaHCO3 (for 14, 15 and 16), I2, and 120 DCM at rt for 12 h. 121 The obtained 7-iodo-2,6-diphenyl-2H-pyrazolo [4,3-c] pyridines 13-17 were further 122 used in palladium-catalysed Suzuki-Miyaura cross-coupling reaction (Scheme 2) by 123 adopting a previously reported procedure [67] . Namely, aromatic boronic acids were re-124 acted with compounds 13-17 using palladium acetate as a catalyst and Cs2CO3 as a base 125 in an aqueous ethanol solution under an argon atmosphere. To ensure a short reaction 126 time, cross-coupling reactions were carried out under microwave irradiation, thus giving 127 rise to compounds 18-37. Compounds 18 and 20-37 (Scheme 2) were obtained in fair to 128 excellent yields (48-96%), but the full cross-coupling conversion of 13 using 2-methoxy-129 phenyl boronic acid could not be achieved, resulting in a lower yield of compound 19.

Synthesis of 4-substituted 7-iodo-2,6-diphenyl-2H-pyrazolo [4,3-c] pyridines (13) (14) (15) (16) (17) . Reagents and conditions: i: in accordance to ref. [56] ; ii: NaBH 4 and MeOH at 0 • C for 30 min (for 3); MeMgBr, EtMgBr, iPrMgCl, or PhMgBr and THF (abs.) at rt for 10 min (for 4, 5, 6 and 7); iii: TMSN 3 , BF 3 ·Et 2 O, and DCM at rt for 30 min; iv: K 3 PO 4 (for 13 and 17) or NaHCO 3 (for 14, 15 and 16), I 2 , and DCM at rt for 12 h.

The obtained alcohols 3-7 were further converted into azides 9-12, respectively. Many methods have been developed for such a transformation, including Mitsunobu-type displacements [60, 61] , two-step procedures that involve a halogenated [62] or mesylated intermediate [63] , the one-pot halogenation-azidation of alcohols [64] , reactions with phosphitine intermediates [65] , N-methyl-2-pyrolidone hydrosulphate, and trimethylsilylazide (TMSN 3 ) [51] . The latter method was chosen for the synthesis, and the reactions were performed in DCM with a catalytic amount of boron trifluoride diethyl etherate (BF 3 ·Et 2 O). The reactions were carried out at room temperature under an argon atmosphere and with a dry solvent in order to protect both the boron trifluoride and TMSN 3 from moisture (Scheme 1). Conversion was completed in 30 minutes, and the reaction products 8-12 were furnished in 50-93% yields.

The newly synthesized azides 8-12 were further used to form the pyrazolo [4,3c] pyridine core with iodine in the 7-position by adopting electrophilic substitution reaction conditions that were previously used to obtain 1,3,4-trisubstituted isoquinolines from 2-alkynyl benzyl azides [66] . Namely, azides 8-12 were dissolved in DCM and treated with iodine and a proper base (Scheme 1). Five equivalents of K 3 PO 4 were used for the primary azides 8 and 12, while one equivalent of NaHCO 3 was used for the secondary azides 9-11. The reactions were carried out at room temperature in the dark for 12 h, furnishing compounds 13-17 in 70-88% yields. An attempt to make use of a weaker base NaHCO 3 for the reaction with the primary azide 6 led to the formation of the dehalogenated side product 2,6-diphenyl-2H-pyrazolo [4,3-c] pyridine, which resulted in a troublesome purification and a lower yield of the target product.

The obtained 7-iodo-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridines 13-17 were further used in palladium-catalysed Suzuki-Miyaura cross-coupling reaction (Scheme 2) by adopting a previously reported procedure [67] . Namely, aromatic boronic acids were reacted with compounds 13-17 using palladium acetate as a catalyst and Cs 2 CO 3 as a base in an aqueous ethanol solution under an argon atmosphere. To ensure a short reaction time, cross-coupling reactions were carried out under microwave irradiation, thus giving rise to compounds 18-37. Compounds 18 and 20-37 (Scheme 2) were obtained in fair to excel-lent yields (48-96%), but the full cross-coupling conversion of 13 using 2-methoxyphenyl boronic acid could not be achieved, resulting in a lower yield of compound 19. Scheme 3. Synthesis of compounds 40-42. Reagents and conditions: i: NaH, RI, and DMF at 70 • C for 1 h.

The fluorescence properties of all final compounds 18-42 were first investigated in THF, with the excitation wavelength λ ex being set to 350 nm (Table S1 , Supplementary File). The emission maxima λ em of all the compounds were located in the 437-487 nm range, which corresponds to the blue part of the visible light spectrum. A polar 4-hydroxyphenyl substituent at the 7-position bearing compounds 23, 29, and 37, as well as derivatives 31-32, 38, 40-42 (all of which bear 4-alkoxyphenyl substituents at the 7-position and ethyl or isopropyl substituents at the 4-position), possessed the most pronounced fluorescence properties. Namely, the Stokes shifts for these compounds were in 199-205 nm range, and the quantum yield reached approximately 60-85%.

Intracellular pH plays an important role in many biological processes, and its changes from normal to abnormal levels can lead to cellular dysfunction, various diseases, and a decrease in physical performance [68] . pH-sensitive fluorescent indicators enable the precise measurement of intracellular pH, which consequently provides valuable information about ongoing physiological and pathological processes at the cellular and sub-cellular levels [69] . To assess whether the fluorescence properties of the prepared compounds are pH-dependent, they were all analysed in pH 5, 7, and 9 buffers with the excitation wavelength λ ex set to 360 nm (Table S2 , Supplementary File). The quantum yield of compounds 18, 24, and 30, all of which bear phenyl substituent at the 7-position, increased at acidic pH without substantial shifts in emission maxima, which were observed to be in the 435-447 nm range. The further analysis of compound 18 in a range of pH 2-11 buffers revealed a gradual decrease in fluorescence intensity with the increase of pH (Figure S1A, Supplementary File) . On the other hand, the quantum yield of 2-methoxyphenyl or 4-methoxyphenyl substituent at the 7-position possessing compounds 19, 21, 25, 27, and 31 was higher in basic pH; moreover, in the case of 4-methoxyphenyl substituent at the 7-position bearing compounds 21, 27, and 31, an acidic pH caused the red shift of the emission maxima. For instance, in the case of compound 21, the emission spectrum was found to be composed of two partly overlapping bands ( Figure S1B , Supplementary File). The short-wavelength part is pH-sensitive. It is dominant in the basic environment, and decreasing the pH from 11 to 6 caused a decrease in fluorescence intensity without a shift in emission maxima, which was maintained at 458 nm. After a further decrease of pH, it was the long-wavelength band that became more dominant, which was manifested as a gradual shift of emission maxima to 519 nm. Any other 4-alkoxyphenyl substituent at the 7-position bearing compounds only exhibited a drop of quantum yield at acidic pH without the shift of the emission maxima. A polar 4-hydroxyphenyl substituent at the 7-position bearing compounds 23, 29, and 37, which possessed the highest quantum yields in THF, had the lowest quantum yields of up to 0.3% in an aqueous solution. It is well known that hydroxyphenyl groups are sensitive to photochemical reactions [70] . Typically, their pK a drops from~10 in the ground state to~3 in the excited state, and excited-state proton transfer reactions are common in aqueous solutions. For our molecules, these reactions resulted in fluorescence quenching. Our preliminary observations suggested that most of the compounds, except for the polar derivatives 23, 29, and 37, could be of potential interest as pH indicators. Considering the approximately 5-fold quantum yield increase and 40 nm blue shift of the emission spectrum maximum when moving from pH 5 to 9, the compound 21 seems to be the best pH indicator from the set of examined molecules, enabling both fluorescence-intensity-based and ratiometric pH sensing.

Synthesized 2H-pyrazolo[4,3-c]pyridines 18-42 were evaluated for their antiproliferative activity against three human cancer cell lines, i.e., MV4-11 (biphenotypic B myelomonocytic leukaemia cells), K562 (chronic myeloid leukaemia cells), and MCF-7 (human breast cancer cells) ( Table 1 ). In agreement with our previous observations [54] , increasing the bulkiness of the substituent at the 4-position gradually reduced or completely abolished the activity of 2H-pyrazolo[4,3-c]pyridine derivatives. Namely, while methyl-substituted compounds 24-29 possessed lower antiproliferative values than their unsubstituted counterparts 18-23, isopropyl-, ethyl-, and phenyl-substituted compounds were mostly nonactive up to the tested 10 µM concentration. Overall, a polar 4-hydroxyphenyl substituent at the 7-position bearing the 4-unsubstituted derivative 23 proved to be the most potent.

Subsequently, the effects of the most active compound 23, its less active 4-substituted analogues 29 and 37, and derivative 21 were studied on K562 leukemic cells. Asynchronously growing K562 cells were treated with 10 µM concentrations of selected compounds for 24, 48, and 72 h and analysed using immunoblotting and flow cytometry ( Figure 2 ). Immunoblotting revealed that 48 h treatment with the most potent compound 23 was sufficient for the induction of poly(ADP-ribose) polymerase 1 (PARP-1) cleavage [71] and the activation of initiator enzyme of apoptotic cascade caspase 9 [72] . Interestingly, in addition to the clear pro-apoptotic effects, we also observed the time-dependent fragmentation of microtubule-associated protein 1-light chain 3 (LC3), which has appeared during autophagy [73] . Similar outcomes with lower efficiencies were observed in all tested compounds. In addition to cell-death-related proteins, the expression levels of proliferating cell nuclear antigen (PCNA), which plays a key role in DNA replication [74] , were analysed. The results revealed that all studied compounds reduced the levels of PCNA time-dependently, with the most pronounced effect observed for compounds 23 and 29. To independently support this observation, immunoblotting was complemented with the flow cytometric analysis of bromodeoxyuridine (BrdU) incorporation, which allowed us to recognize replicating BrdU-positive cells in the population [75] ( Figure 2B ). In control samples the number of proliferating cells came up to 40%, but the 10 µM treatment with tested compounds 21, 23, 29, and 37 reduced the proportion of actively proliferating BrdU-positive cells in up to approximately 10% for the most active compounds 23 and 29. Overall, the obtained results suggest the complex action of the compounds, combining antiproliferative effects with the induction of cell death. 

All chemicals and solvents were purchased from commercial suppliers and used without further purification unless otherwise specified. The 1 H, 13 C, and 15 N NMR spectra were recorded in CDCl 3 or DMSO-d 6 solutions at 25 • C on either a Bruker Avance III 700 (700 MHz for 1 H, 176 MHz for 13 C, and 71 MHz for 15 N) spectrometer equipped with a 5 mm TCI 1 H-13 C/ 15 N/D z-gradient cryoprobe or a Jeol ECA-500 (500 MHz for 1 H and 126 MHz for 13 C) spectrometer equipped with a 5 mm Royal probe. The chemical shifts, expressed in ppm, were relative to tetramethylsilane (TMS). The 15 N NMR spectra were referenced to neat, external nitromethane (coaxial capillary). The 19 F NMR spectra (376 MHz) were obtained on a Bruker Avance III 400 instrument using C 6 F 6 as an internal standard. FT-IR spectra were collected using the ATR method on a Bruker Vertex 70v spectrometer with an integrated Platinum ATR accessory or on a Bruker Tensor 27 spectrometer in KBr pellets. The melting points of crystalline compounds were determined in open capillary tubes with a Buchi M 565 apparatus (temperature gradient: 2 • C/min) and are uncorrected. Mass spectra were recorded on Q-TOF MICRO spectrometer (Waters), analyses were performed in the positive (ESI + ) mode, and molecular ions were recorded in [M + H] + forms. High-resolution mass spectrometry (HRMS) spectra were obtained in the ESI mode on a Bruker MicrOTOF-Q III spectrometer. All reactions were performed in oven-dried flasks under an argon atmosphere with magnetic stirring. Reaction progress was monitored by TLC analysis on Macherey-Nagel™ ALUGRAM ® Xtra SIL G/UV254 plates. TLC plates were visualized with UV light (wavelengths of 254 and 365 nm) or iodine vapour. Compounds were purified by flash chromatography in a glass column (stationary phase of silica gel, high-purity grade of 9385, pore size of 60 Å, particle size of 230-400 mesh, supplied by Sigma-Aldrich). 1 H, 13 

was dissolved in MeOH (12 mL), and the solution was cooled to 0 • C. Subsequently, NaBH 4 (156 mg, 4.12 mmol) was added under an argon atmosphere, and the mixture was stirred for 30 min. Upon completion (monitored by TLC), the reaction mixture was diluted with a saturated aqueous NH 4 Cl solution (20 mL) and extracted with EtOAc (3 × 30 mL). The combined organic layers were dried over anhydrous Na 2 SO 4 , filtered, and evaporated under reduced pressure. The residue was purified by column chromatography (EtOAc/Hex, 1:3 v/v). 

1-Phenyl-3-(2-phenylethynyl)-1H-pyrazole-4-carbaldehyde 2 (1 equivalent) was dissolved in dry THF under an argon atmosphere. Subsequently, an appropriate Grignard reagent (1.2 equivalents) was added, and the mixture was stirred at room temperature for 10 min. Upon completion (monitored by TLC), the reaction mixture was diluted with water (20 mL) and extracted with EtOAc (3 × 20 mL). The combined organic layers were dried over anhydrous Na 2 SO 4 , filtered, and evaporated under reduced pressure. The residue was purified by column chromatography.

1-[1-Phenyl-3-(phenylethynyl)-1H-pyrazol-4-yl]ethanol-1-ol 4 was prepared in accordance with general procedure (A) from 1-phenyl-3-(2-phenylethynyl)-1H-pyrazole-4carbaldehyde 2 (350 mg, 1.287 mmol) and MeMgCl (0.52 mL, 1.56 mmol) in THF (4 mL). The desired compound was purified by column chromatography (EtOAc/Hex, 1:4 v/v). To a solution of appropriate pyrazole alcohol 3-7 (1 equivalent) in dry DCM, TMSN 3 (1.5 equivalents) and BF 3 ·Et 2 O (0.2 equivalents) were added dropwise. The reaction mixture was stirred for 10-60 min under an argon atmosphere at room temperature. Upon completion (monitored by TLC), the reaction mixture was diluted with an aqueous NaHCO 3 solution (10 mL) and extracted with DCM (3 × 25 mL). The combined organic layers were dried over anhydrous Na 2 SO 4 , filtered, and evaporated under reduced pressure. The residue was purified by column chromatography. To a solution of appropriate azide-alkyne 8-12 (1 equivalent) in DCM, the appropriate base K 3 PO 4 (5 equivalents) or NaHCO 3 (1 equivalent) and I 2 (5 equivalents) were added. The reaction mixture was stirred at room temperature for 12 h. Upon completion (monitored by TLC), the reaction mixture was diluted with an aqueous Na 2 S 2 O 4 solution (20 mL) and extracted with EtOAc (3 × 25 mL). The combined organic layers were dried over anhydrous Na 2 SO 4 , filtered, and evaporated under reduced pressure. The residue was purified by column chromatography. 2 equivalents) , Cs 2 CO 3 (2 equiv-alents), and Pd(OAc) 2 (0.07 equivalents) were added under argon atmosphere. The mixture was stirred at 100 • C under microwave irradiation (100 W and 300 Pa) for 0.5-1 h. Upon completion (monitored by TLC), the reaction mixture was cooled to room temperature and filtered through a pad of Celite, and the filter cake was washed with EtOAc (20 mL). The filtrate was diluted with water (20 mL) and extracted with EtOAc (3 × 25 mL). The combined organic layers were washed with brine (10 mL), dried over anhydrous Na 2 SO 4 , filtered, and evaporated under reduced pressure. The residue was purified by column chromatography. 

The UV-vis spectra of 10 −4 mol solutions of the compounds in THF were recorded on a Shimadzu 2600 UV/vis spectrometer. The fluorescence spectra were recorded on an FL920 fluorescence spectrometer from Edinburgh Instruments. The PL quantum yields (Φ f ) were measured from dilute THF solutions by an absolute method using the Edinburgh Instruments integrating sphere excited with a Xe lamp. The optical densities of the sample solutions were ensured to be below 0.1 to avoid reabsorption effects. All optical measurements were performed at room temperature under ambient conditions. 

Stock solutions (4 mM) of the compounds were prepared in DMSO and further diluted in a Britton-Robinson buffer to a final concentration of 2 µM for spectroscopic analyses. Absorption spectra at pH 5, 7, and 9 for all compounds and in the 2-11 pH range with 0.5 step for selected compounds were measured using a Specord 250 Plus spectrophotometer in appropriate Britton-Robinson buffers. The spectra were measured in the 240-450 nm interval with a step of 1 nm, a 1 nm bandpass, and an integration time of 0.5 s. The samples were placed into a quartz cuvette with an optical path of 1 cm. The baseline was measured for the cuvette containing the solvent only.

The steady-state excitation and emission spectra of 2 µM solutions of all the compounds at pH 5, 7, and 9 and in the 2-11 pH range with a 0.5 step for selected compounds were recorded on a Fluorolog-3 fluorimeter in the quartz cuvette with the 1 cm optical path (both in excitation and emission). Bandpasses in both the excitation and emission monochromator were set to 2 nm, and the spectra were scanned with the 1 nm step and an integration time 0.2 s per data point at 22 • C. Emission spectra were recorded in a 370-700 nm range with excitation at 360 nm.

The quantum yield was estimated via integration of the fluorescence intensity over a range of 370-700 nm, and a 2.5 µM quinine sulphate solution in 0.05 M H 2 SO 4 was used as a standard (Φ f = 60%) [76] .

The data that support the findings of this study are available upon request.

CH=CH monosubstituted benzenes). MS (ES + ): m/z (%)

HRMS (ESI) for C 26 H

Pd(OAc) 2 (3 mg, 0.013 mmol), EtOH (1.2 mL), and water (0.4 mL). The reaction was finished after 30 min. The desired compound was obtained after purification by column chromatography (EtOAc/Hex, 1:5 v/v)

IR (KBr, ν, cm −1 ): 3058, 3016 (CH arom

MS (ES + ): m/z (%): 405 ([M + H] + , 99). HRMS (ESI) for C 27 H 24 N 3 O ([M + H] + ): requires 406.1914 and found 406

Pd(OAc) 2 (3 mg, 0.013 mmol), EtOH (1.2 mL), and water (0.4 mL). The reaction was finished after 30 min. The desired compound was obtained after purification by column chromatography (EtOAc/Hex, 1:5 v/v)

HRMS (ESI) for C 28 H

3-c]pyridine 33 was prepared in accordance with general procedure (D) from 7-iodo-4-methyl 2,6-diphenyl-2H-pyrazolo[4,3-c]pyridine 15 (80 mg, 0.19 mmol), (4-methylphenyl)boronic acid (31 mg, 0.23 mmol), Cs 2 CO 3 (123 mg, 0.38 mmol), Pd(OAc) 2 (3 mg, 0.013 mmol), EtOH (1.2 mL), and water (0.4 mL). The reaction was finished after 30 min. The desired compound was obtained after purification by column chromatography (EtOAc/Hex, 1:8 v/v). Yield: 60 mg (81%), yellowish crystalline solid, mp = 179-180 • C

51 (4H, m, NPh 3,5-H and C7Ph 2,6-H), 7.86-7.91 (2H, m, NPh 2,6-H), 8.59 (1H, s, 3-H). 13 C NMR (176 MHz

3-c]pyridine 34 was prepared in accordance with general procedure (D) from 7-iodo-4-methyl 2,6-diphenyl-2H-pyrazolo[4,3-c]pyridine 15 (80 mg, 0.19 mmol), 4-(trifluoromethyl)phenylboronic acid (43 mg, 0.23 mmol), Cs 2 CO 3 (123 mg, 0.38 mmol), Pd(OAc) 2 (3 mg, 0.013 mmol), EtOH (1.2 mL), and water (0.4 mL). The reaction was finished after 30 min. The desired compound was obtained after purification by column chromatography

NPh 2,6-H), 8.64 (1H, s, 3-H). 13 C NMR (176 MHz

Pd(OAc) 2 (3 mg, 0.013 mmol), EtOH (1.2 mL), and water (0.4 mL). The reaction was finished after 30 min. The desired compound was obtained after purification by column chromatography (EtOAc/Hex, 1:8 v/v)

4-ethyl-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridine 36 was prepared in accordance with general procedure (D) from 7-iodo-4-methyl 2,6-diphenyl-2H-pyrazolo [4,3-c]pyridine 15 (80 mg, 0.19 mmol), 4-chlorophenylboronic acid (36 mg, 0.23 mmol), Cs 2 CO 3 (123 mg, 0.38 mmol), Pd(OAc) 2 (3 mg, 0.013 mmol), EtOH (1.2 mL), and water (0.4 mL). The reaction was finished after 30 min. The desired compound was obtained after purification by column chromatography (EtOAc/Hex, 1:8 v/v). Yield: 65 mg (83%), yellow crystalline solid

93 (2H, m, NPh 2,6-H), 8.61 (1H, s, 3-H). 13 C NMR (176 MHz

HRMS (ESI) for C 26 H

Pd(OAc) 2 (3 mg, 0.013 mmol), EtOH (1.2 mL), and water (0.4 mL). The reaction was finished after 30 min. The desired compound was obtained after purification by column chromatography (EtOAc/Hex, 1:8 v/v)

HRMS (ESI) for C 26 H 22 N 3 O

-methoxyphenyl)-4-methyl-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridine 38 was prepared in accordance with general procedure (D) from 7-iodo-4-isopropyl-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridine 16 (100 mg, 0.23 mmol), 4-methoxyphenyl)boronic acid (42 mg, 0.27 mmol), Cs 2 CO 3 (148 mg, 0.46 mmol), Pd(OAc) 2 (4 mg, 0.015 mmol), EtOH (1.5 mL), and water (0.5 mL). The reaction was finished after 1 h. The desired compound was obtained after purification by column chromatography (EtOAc/Hex, 1:8 v/v). Yield: 80 mg (83%), white crystalline solid

CH-(CH 3 ) 2 ), 3.53 (1H, p

NPh 2,6-H), 8.63 (1H, s, 3-H). 13 C NMR (176 MHz

CH=CH of mono-and disubstituted benzenes). MS (ES + ): m/z (%): 421 ([M + 2H] + , 97.4). HRMS (ESI) for C 28 H 26 N 3 O

3-c]pyridine 39 was prepared in accordance with general procedure (D) from 7-iodo-2,4,6-triphenyl-2H-pyrazolo[4,3-c]pyridine 17 (64 mg, 0.135 mmol), (4-methoxyphenyl)boronic acid (25 mg, 0.16 mmol), Cs 2 CO 3 (88 mg, 0.27 mmol), Pd(OAc) 2 (2 mg, 0.009 mmol), EtOH (0.9 mL), and water (0.3 mL). The reaction was finished after 45 min. The desired compound was obtained after purification by column chromatography (EtOAc/Hex, 1:10 v/v). Yield: 38 mg (62%), yellow crystalline solid

CDCl 3 ): δ 55.2 (CH 3 ), 113.5 (C7Ph C-3,5), 118.1 (C-3a)

CH=CH of mono-and disubstituted benzenes). MS (ES + ): m/z (%)

equivalent) was dissolved in DMF. Then, NaH (60% in mineral oil) completion (monitored by TLC), the reaction mixture was cooled to room temperature, diluted with water (20 mL), and extracted with EtOAc (3 × 25 mL). The combined organic layers were washed with brine (10 mL), dried over anhydrous Na 2 SO 4 , filtered, and evaporated under reduced pressure

-Ethoxyphenyl)-4-ethyl-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridine 40 was prepared in accordance with general procedure (E) from (4-ethyl-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridin-7-yl)phenol 37 (60 mg, 0.15 mmol), NaH (60%) (7 mg, 0.17 mmol), ethyl iodide (0.014 mL, 0.17 mmol), and DMF (2 mL). The desired compound was obtained after purification by column chromatography (EtOAc/Hex, 1:4 v/v). Yield: 62 mg (97%), yellow crystalline solid

43 (3H, m, NPh 4-H and C6Ph 2,6-H), 7.47-7.52 (4H, m, NPh 3,5-H and C7Ph 2,6-H), 7.88-7.93 (2H, m, NPh 2,6-H), 8.60 (1H, s, 3-H)

-propoxyphenyl)-2H-pyrazolo[4,3-c]pyridine 41 was prepared in accordance with general procedure (E) from (4-ethyl-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridin-7-yl)phenol 37 (60 mg, 0.15 mmol), NaH (60%) (7 mg, 0.17 mmol), 1-iodo propane (0.016 mL, 0.17 mmol), and DMF (2 mL). The desired compound was obtained after purification by column chromatography (EtOAc/Hex, 1:6 v/v). Yield: 64 mg (96%), yellow crystalline solid

C7Ph C-2,6), 140.1 (NPh C-1), 141.2 (C6Ph C-1), 148.8 (C-6), 152.0 (C-7a

-isopropoxyphenyl)-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridine 42 was prepared in accordance with general procedure (E) from (4-ethyl-2,6-diphenyl-2H-pyrazolo[4,3-c]pyridin-7-yl)phenol 37 (60 mg, 0.15 mmol), NaH (60%) (7 mg, 0.17 mmol), 2-iodo propane (0.016 mL, 0.17 mmol), and DMF (2 mL). The desired compound was obtained after purification by column chromatography (EtOAc/Hex, 1:6 v/v). Yield: 52 mg (80%), yellow crystalline solid

CDCl 3 ): δ Cultures Human cell lines were obtained from European Collection of Authenticated Cell Cultures (K562, MCF-7) or Cell Lines Service (MV4-11), and they were cultivated according to the provider's instructions. Briefly, the MCF-7 and K562 cell lines were maintained in a DMEM medium

The GI 50 value, the drug concentration lethal to 50% of the cells, was calculated from the dose-response curves

After blocking, overnight incubation with specific primary antibodies, and incubation with peroxidase-conjugated secondary antibodies, the peroxidase activity was detected with SuperSignal West Pico reagents

anti-β-Actin, clone C4), or they were kindly gifted by dr. B. Vojtěšek (Masaryk Memorial Cancer Institute

and 72 h, and 30 min before the end of incubation, the cells were labelled with 10 µM BrdU (Sigma-Aldrich, St. Loius, MO, USA) for 30 min. Subsequently, the cells were washed in PBS, fixed with ice-cold 70% ethanol, and denatured in 2 M HCl. After neutralization, the cells were stained with an anti-BrdU FITC-labelled antibody (eBioscience

-phenylethynyl)-1H-pyrazole-4-carbaldehyde. The obtained compounds were evaluated for their antiproliferative activity against three cancer cell lines. Out of them, 4-(2,6-diphenyl-2H-pyrazolo[4,3-c]pyridin-7-yl)phenol 23 proved to be the most active, and further experiments revealed that it blocks proliferation and induces cell death in K562 cells. Moreover, the majority of the compounds were revealed to be pH-sensitive

Figure S1: Fluorescence spectra (λ ex = 360 nm) and titration profiles for compounds 18 and 21 in a Britton-Robinson buffer at pH 2-11

ESI-TOF) spectra of compounds 3-42, 19 F spectra of compounds 34 and 35, and 1 H-15 N HMBC spectra of compounds 13

writing-original draft preparation

/16_019/0000868) and by the Research Council of Lithuania

Institutional Review Board Statement: Not applicable

Pyrazole containing natural products: Synthetic preview and biological significance

Shamsuzzaman Review: Biologically active pyrazole derivatives

Recent advances in bioactive pyrazoles

Synthesis and photodynamic properties of pyrazole-indole hybrids in the human skin melanoma cell line G361. Dyes Pigment

CNB-001, a novel pyrazole derivative mitigates motor impairments associated with neurodegeneration via suppression of neuroinflammatory and apoptotic response in experimental Parkinson's disease mice

Synthesis and anthelmintic activity of benzopyrano[2,3-c]pyrazol-4(2H)-one derivatives

Synthesis and biological evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives

Discovery of novel pyrazole derivatives as a potent anti-inflammatory agent in RAW264.7 cells via inhibition of NF-kB for possible benefit against SARS-CoV-2

In silico study, synthesis, and evaluation of the antimalarial activity of hybrid dimethoxy pyrazole 1,3,5-triazine derivatives

The therapeutic voyage of pyrazole and its analogs: A review

Synthesis of some novel heterocyclic dyes derived from pyrazole derivatives

Antimicrobial pyrazole dyes: Synthesis, characterization, and absorption characteristics

One-Pot Coupling-Coupling-Cyclocondensation Synthesis of Fluorescent Pyrazoles

Synthesis of pyrazolo[4 ,3 :3,4]pyrido [1,2-a]benzimidazoles and related new ring systems by tandem cyclisation of vic-alkynylpyrazole-4-carbaldehydes with (het)aryl-1,2-diamines and investigation of their optical properties

Recent progress in chemosensors based on pyrazole derivatives

Remarkable colorimetric sensing behavior of pyrazolebased chemosensor towards Cu(II) ion detection: Synthesis, characterization and theoretical investigations

A chemosensor for heavy-transition metal ions in mixed aqueous-organic media

Diaminomaleonitrile based chromo-fluorescent receptor molecule for selective sensing of Mn(II) and Zn(II) ions

Cd(II), and Hg(II) Optical Detection

Synthesis of Novel D-π-A Dyes for Colorimetric Cyanide Sensing Based on Hemicyanine-Functionalized N-(2-Pyridyl)pyrazoles

Synthesis of Dicyanovinyl-Substituted 1-(2-Pyridyl)pyrazoles: Design of a Fluorescent Chemosensor for Selective Recognition of Cyanide

Pyrazole-substituted near-infrared cyanine dyes exhibit pH-dependent fluorescence lifetime properties

Novel Turn-on Fluorescence Probes for Al 3+ Based on Conjugated Pyrazole Schiff Base

A new fluorescence turn-on chemosensor for nanomolar detection of Al 3 + constructed from a pyridine-pyrazole system

A novel 8-hydroxyquinoline-pyrazole based highly sensitive and selective Al(III) sensor in a purely aqueous medium with intracellular application: Experimental and computational studies

Simple pyrazoline and pyrazole "turn on" fluorescent sensors selective for Cd 2+ and Zn 2+ in MeCN

Selective Ag(I) binding, H 2 S sensing, and white-light emission from an easy-to-make porous conjugated polymer

A novel pyrazole based single molecular probe for multi-analyte (Zn 2+ and Mg 2+ ) detection in human gastric adenocarcinoma cells

Pyrazole appended quinoline-BODIPY based arene ruthenium complexes: Their anticancer activity and potential applications in cellular imaging

Anticancer Activity of Iridium(III) Complexes Based on a Pyrazole-Appended Quinoline-Based BODIPY

Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells

Kit inhibitor APcK110 extends survival in an AML xenograft mouse model

APCK110, a Novel and Potent Inhibitor of c-Kit, Blocks Phosphorylation of AKT and STAT3, Induces Apoptosis, and Inhibits Proliferation of Acute Myeloid Leukemia (AML) Cells

Identification of 1H-pyrazolo[3,4-b]pyridine derivatives as potent ALK-L1196M inhibitors

Structure-Based Optimization of Potent, Selective, and Orally Bioavailable CDK8 Inhibitors Discovered by High-Throughput Screening

Structural Basis for PPARα Activation by 1H-pyrazolo

Synthesis, molecular modeling and biological evaluation of new pyrazolo[3,4-b]pyridine analogs as potential antimicrobial, antiquorum-sensing and anticancer agents

3-Amino-1H-pyrazolopyridine Derivatives as a Maternal Embryonic Leucine Zipper Kinase Inhibitor

Fragment-based discovery of 6-azaindazoles as inhibitors of bacterial DNA ligase

Discovery and characterization of N-(1,3-dialkyl-1H-indazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine scaffold as mGlu 4 positive allosteric modulators that mitigate CYP1A2 induction liability

Synthesis, and Preclinical Characterization of N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu 4 )

Design and Synthesis of New Substituted Pyrazolopyridines with Potent Antiproliferative Activity

Novel pyrazolopyridine derivatives as potential angiogenesis inhibitors: Synthesis, biological evaluation and transcriptome-based mechanistic analysis

Identification of Inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model

Design and evaluation of 3-aminopyrazolopyridinone kinase inhibitors inspired by the natural product indirubin

Synthesis of pyridyl substituted pyrazolo[4,3-c]pyridines as potential inhibitors of protein kinases

Dipyrazolo[1,5-a:4',3'-c]pyridines-A new heterocyclic system accessed via multicomponent reaction

Synthesis of trifluoromethyl-substituted pyrazolo[4,3-c]pyridines-Sequential versus multicomponent reaction approach

Sonogashira-type reactions with 5-chloro-1-phenyl-1H-pyrazole-4-carbaldehydes: A straightforward approach to pyrazolo[4,3-c]pyridines

Metal-Free Intramolecular Alkyne-Azide Cycloaddition To Construct the Pyrazolo

Ethyl 3-and 5-triflyloxy-1H-pyrazole-4-carboxylates in the synthesis of condensed pyrazoles by Pd-catalysed cross-coupling reactions

Ring-closing metathesis as a key step to construct 2,6-dihydropyrano[2,3-c]pyrazole ring system

Synthesis and anti-mitotic activity of 2,4-or 2,6-disubstituted-and 2,4,6-trisubstituted-2H-pyrazolo[4,3-c]pyridines

Synthesis of 3-substituted 1-phenyl-1H-pyrazole-4-carbaldehydes and the corresponding ethanones by Pd-catalysed cross-coupling reactions

Synthesis and pharmacological evaluation of new N-phenylpiperazine derivatives designed as homologues of the antipsychotic lead compound LASSBio-579

Reaction of Grignard reagents with carbonyl compounds under continuous flow conditions

The Oxidation of Grignard Reagents

Direct azidation of unprotected carbohydrates under Mitsunobu conditions using hydrazoic acid

The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products

Organic Azides: Syntheses and Applications

Selective Elaboration of Aminodiols towards Small Ring α-and β-Amino Acid Derivatives that Incorporate an Aziridine, Azetidine, or Epoxide Scaffold

A Tractable and Efficient One-Pot Synthesis of 5 -Azido-5 -deoxyribonucleosides

Conversion of tertiary alcohols to tert-alkyl azides by way of quinone-mediated oxidation-reduction condensation using alkyl diphenylphosphinites

Iodine-Mediated Electrophilic Cyclization of 2-Alkynyl-1-methylene Azide Aromatics Leading to Highly Substituted Isoquinolines and Its Application to the Synthesis of Norchelerythrine

Microwave-assisted synthesis of new fluorescent indoline-based building blocks by ligand free Suzuki-Miyaura cross-coupling reaction in aqueous media

Importance of pH Homeostasis in Metabolic Health and Diseases: Crucial Role of Membrane Proton Transport

Fluorescent indicators for intracellular pH

Fluorescence investigations of phenol phototransformation in aqueous solutions

PARP1-driven apoptosis in chronic lymphocytic leukemia

Regulation of Caspase 9 through Phosphorylation by Protein Kinase C Zeta in Response to Hyperosmotic Stress

Following autophagy step by step

PCNA on the crossroad of cancer

Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry

Reevaluation of absolute luminescence quantum yields of standard solutions using a spectrometer with an integrating sphere and a back-thinned CCD detector

The authors are grateful to A. Bieliauskas (Kaunas University of Technology) for preliminary fluorescence measurements.

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.Sample Availability: Not available.